There have also been reports indicating that therapeutic agents can attenuate the aggregation of CD68+ macrophages in the peritoneum, serving as a marker for mouse M1 macrophages in animal models of peritoneal fibrosis while alleviating peritoneal fibrosis. Here, CD68 is linked to Peritoneal Fibrosis.